Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

NCT03478280 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Brodalumab
DRUG: Placebos

Sponsor

Aarhus University Hospital

Collaborators

[object Object]